These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6806351)

  • 1. [The effect of beta-lactam antibiotics on P. aeruginosa].
    Suginaka H
    Hiroshima Daigaku Shigaku Zasshi; 1981 Dec; 13(2):359. PubMed ID: 6806351
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility of Proteus species and Pseudomonas aeruginosa to penicillins and cephalosporins.
    Adler JL; Burke JP; Wilcox C; Finland M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():63-7. PubMed ID: 5000270
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parallel resistance between cephalosporins and penicillins].
    Grimm H
    Arzneimittelforschung; 1984; 34(1):62-5. PubMed ID: 6422952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antibacterial activity of penicillins and cephalosporins in relation to the inoculum size].
    Baier R; Puppel H
    Med Welt; 1981 May; 32(19):738-42. PubMed ID: 6785549
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
    Cavallo JD; Leblanc F; Fabre R
    Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-lactamine associations. In vitro synergism and clinical results].
    Acar JF
    Pathol Biol (Paris); 1971; 19(11):593-7. PubMed ID: 4997292
    [No Abstract]   [Full Text] [Related]  

  • 9. Peptidoglycan transpeptidase inhibition in Pseudomonas aeruginosa and Escherichia coli by Penicillins and Cephalosporins.
    Moore BA; Jevons S; Brammer KW
    Antimicrob Agents Chemother; 1979 Apr; 15(4):513-7. PubMed ID: 111613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-lactam antibiotics on the in vitro development of resistance in Pseudomonas aeruginosa.
    Carsenti-Etesse H; Cavallo JD; Roger PM; Ziha-Zarifi I; Plesiat P; Garrabe E; Dellamonica P
    Chirurgia (Bucur); 2002; 97(2):151-9. PubMed ID: 12731225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro action of new beta-lactams on hospital strains of Pseudomonas aeruginosa producing beta-lactamases ].
    Moillo-Batt A; Shacoori ZT
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):510-2. PubMed ID: 6812004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of incubation temperature on the sensitivity of Yersinia enterocolitica and pseudotuberculosis to 8 beta-lactam antibiotics].
    Gaspar Gascó MC; Vega Ramos J; Soriano García F
    Rev Clin Esp; 1981 Nov; 163(3):161-2. PubMed ID: 7330353
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
    Wu YL; Scott EM; Po AL; Tariq VN
    APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of cefoperazone and penicillins alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Pot CM; Westerdaal NA
    J Antimicrob Chemother; 1981 Aug; 8(2):101-6. PubMed ID: 6456254
    [No Abstract]   [Full Text] [Related]  

  • 16. Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.
    Vahaboglu H; Saribaş S; Akbal H; Ozturk R; Yucel A
    J Antimicrob Chemother; 1998 Aug; 42(2):269-70. PubMed ID: 9738851
    [No Abstract]   [Full Text] [Related]  

  • 17. Biosynthesis of peptidoglycan in Pseudomonas aeruginosa. 2. Mode of action of beta-lactam antibiotics.
    Mirelman D; Nuchamowitz Y
    Eur J Biochem; 1979 Mar; 94(2):549-56. PubMed ID: 107030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity in vitro of 32 strains of Pseudomonas aeruginosa to carbenicillin].
    Bertaggia A; De Negri M
    G Mal Infett Parassit; 1971 Nov; 23(11):1047-50. PubMed ID: 5004851
    [No Abstract]   [Full Text] [Related]  

  • 19. Part II. Introduction to the beta-lactam antibiotics.
    Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
    [No Abstract]   [Full Text] [Related]  

  • 20. Accuracy of cefepime antimicrobial susceptibility testing results for Pseudomonas aeruginosa tested on the MicroScan WalkAway System.
    Biedenbach DJ; Marshall SA; Jones RN
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):305-7. PubMed ID: 10212758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.